Daniel Ritchie

Daniel Ritchie is an experienced professional in quality control microbiology, currently serving as the Quality Control Microbiology Manager at CRISPR Therapeutics since May 2021. Prior roles include Quality Control Microbiology Supervisor at Advanced Compounding Solutions and Senior Quality Control Analyst at Quanterix. Daniel has also held positions at Histogenics Corporation, Genzyme, and Validation Technologies, focusing on environmental qualification studies, deviations investigations, and microbiological testing and analyses. Daniel holds a B.S. in Biotechnology from Worcester Polytechnic Institute and has gained international experience during a program at HTWG Hochschule Konstanz.